例句與造句

1. CMKLR1, GPR32, and FPR2 have been proposed to be the GPR through which these resolvins act.
2. Metabolically stable analogs of the SPMs, including the resolvins, are in development and being tested in volunteers with chronic inflammation-related diseases.
3. The eicosapentaenoic acid found in fish oils appears to dramatically reduce inflammation through conversion within the body to resolvins, with beneficial effects for the cardiovascular system and arthritis.
4. There are multiple subfamilies of eicosanoids, including most prominently the prostaglandins, thromboxanes, leukotrienes, lipoxins, resolvins, and eoxins but also others as noted in the following Nomenclature section.
5. While all of the resolvins possess one or more anti-inflammatory activity as accessed on in vitro model systems, not all of the resolvins have been studied for activity in vivo as long or as thoroughly as RvE1 and RvD1.
6. It's difficult to find resolvins in a sentence. 用resolvins造句挺難的
7. While all of the resolvins possess one or more anti-inflammatory activity as accessed on in vitro model systems, not all of the resolvins have been studied for activity in vivo as long or as thoroughly as RvE1 and RvD1.
8. However, the most studied and accepted role for FPR2 receptors is in mediating the actions of the cited lipoxins and resolvins in dampening and resolving a wide range of inflammatory reactions ( see lipoxin, Epi-lipoxin, and resolvin ).
9. Both receptor types bind and are activated by a series of formylated oligopeptide chemotactic factors but FLP2 receptor appears to be a promiscuous receptor in that it also binds to and is activated by lipoxins and resolvins as well as various polypeptides and proteins.
10. "' Resolvins "'are autacoids of a specific lipid structure : dihydroxy or trihydroxy metabolites of omega-3 fatty acids, primarily eicosapentaenoic acid ( EPA ) and docosahexaenoic acid ( DHA ) but also the docosapentaenoic acid ( DPA ), clupanodonic acid.
11. Resolvin E1 ( RvE1 ), RvD2 ( see resolvins ), neuroprotectin D1 ( NPD1 ), and maresin 1 ( Mar1 ) are metabolites of the omega 3 fatty acids, eicosapentaenoic acid ( for RvE1 ) or docosahexaenoic acid ( for RvD2, NPD1, and Mar1 ).
12. By metabolizing ?-3 polyunsaturated fatty acids, eicosapentaenoic acid and docosahexaenoic acid, into lipoxins and resolvins, 15-LOX-1 is thought to be one mechanism by which dietary ?-3 polyunsaturated fatty acids, particularly fish oil, may act to reduce the incidence and / or progression of certain cancers.
13. At least 6 members of the D series of resolvins ( RvDs ) viz ., RvD1, RvD2m AT-RVD1, RvD3, AT-RvD3, and RvD5, activate their target cells through this receptor; these results have led to naming GPR32 the RVD1 receptor ( see Resolvin # Mechanisms of Action ).
14. For example, ALOX5 acts with ALOX12 or aspirin-treated COX-2 to metabolize arachidonic acid to lipoxins and with cytochrome P450 monooxygenase ( s ), bacterial cytochrome P450 ( in infected tissues ), or aspirin-treated COX2 to metabolize eicosapentaenoic acid to the E series resolvins ( RvEs ) ( see Specialized pro-resolving mediators ).
15. The following oxygenase enzymes are responsible for metabolizing PUFA to resolvins : 15-lipoxygenase-1 ( i . e . ALOX15 ), possibly 15-lipoxygenase-2 ( i . e . ALOX15B ), 5-lipoxygenase ( i . e . ALOX5 ), cyclooxygenase-2 ( i . e . COX-2 ), and certain Cytochrome P450 monooxygenases.
16. By metabolizing the ?-3 polyunsaturated fatty acids, eicosapentaenoic acid and docosahexaenoic acid, into 17-HpDHA, 17-HDHA, and the resolvins and protectins, 15-LOX-1's metabolic action is thought to be one mechanism by which dietary ?-3 polyunsaturated fatty acids, particularly fish oil, act to ameliorate inflammation, inflammation-related diseases, and certain cancers.
更多例句：  下一頁